Lower riskMedical device recall · FDA · Published December 16, 2019
Nextremity Stratum Lapidus Plate Recall: Wrong Plate Type Risk
Nextremity Solutions recalls Stratum Lapidus Plate (Part No. STRM-LAP-SMR) due to incorrect plate type. This could cause improper bone fixation. Affected units have UDI 00817701025467.
“Nextremity Stratum Lapidus Plate Recall: Wrong Plate Type Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/66317-nextremity-stratum-lapidus-plate-recall-wrong-plate-type-risk. Based on FDA recall #Z-1127-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1127-2020%22&limit=1).
The FDA announced on 2019-12-16 that Nextremity Solutions is recalling the Stratum Lapidus Plate - Small Rt due to labeling errors. The package indicates a right plate but contains a left plate, posing a risk of incorrect surgical use. This voluntary Class II recall involves 40 units distributed domestically.
How to tell if you have it
Brand: Nextremity Solutions
Product: Stratum Lapidus Plate - Small Rt
Part No.: STRM-LAP-SMR
UDI: 00817701025467
Lot: M1502
The hazard
The product contains a different plate than indicated by the package labeling. Specifically, the item is labeled as a right plate but actually contains a left plate.
Context
GovInfoNow's records show Nextremity Solutions has had 6 other recalls since 2019-10-09. Other recent recalls of similar products include Waldemar Link Endo-Model Tibial Plateau Recall (2026-07-06), restor3d Veritas Standard Glenoid Baseplate Recall (2026-06-30), and Howmedica Triathlon Baseplate Size 3 Recall (2026-05-19).
How to tell if you have this one
Check for the product name 'Stratum Lapidus Plate - Small Rt' with part number STRM-LAP-SMR. Affected units have a unique device identifier (UDI) starting with 00817701025467.
Brand
Nextremity Solutions
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the plate's part number and unique device identifier (UDI) to confirm if it matches the recalled model.
Where it went and when
Where it was distributed
Distributed in 22 states.
Listed by the agency
Not listed
FDA distribution: “Domestic distribution to AL, CA, FL, GA, ID, IL, IA, KY, LA, ME, MA, MI, MN, MS, NE, NJ, NY, OH ,OK, OR, TX, and WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, California, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Nebraska, New Jersey, New York, Ohio, Oklahoma, Oregon, Texas, Washington.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1127-2020 (December 16, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1127-2020 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.